Chemoinformaics analysis of 4-FLUORO-2-METHOXYPHENOL
| Molecular Weight | 142.129 | nRot | 1 |
| Heavy Atom Molecular Weight | 135.073 | nRig | 6 |
| Exact Molecular Weight | 142.043 | nRing | 1 |
| Solubility: LogS | -0.898 | nHRing | 0 |
| Solubility: LogP | 1.468 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 18.5186 |
| nHD | 1 | BPOL | 9.87145 |
| QED | 0.644 |
| Synth | 1.551 |
| Natural Product Likeliness | -0.368 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.02 |
| HIA | 0.004 |
| CACO-2 | -4.386 |
| MDCK | 0.0000233 |
| BBB | 0.307 |
| PPB | 0.852297 |
| VDSS | 1.31 |
| FU | 0.0959369 |
| CYP1A2-inh | 0.871 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.429 |
| CYP2c19-sub | 0.683 |
| CYP2c9-inh | 0.112 |
| CYP2c9-sub | 0.883 |
| CYP2d6-inh | 0.327 |
| CYP2d6-sub | 0.903 |
| CYP3a4-inh | 0.059 |
| CYP3a4-sub | 0.295 |
| CL | 13.733 |
| T12 | 0.834 |
| hERG | 0.029 |
| Ames | 0.077 |
| ROA | 0.538 |
| SkinSen | 0.717 |
| Carcinogencity | 0.71 |
| EI | 0.989 |
| Respiratory | 0.712 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.880946 |